During the past decade, BFHC Research conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BFHC Research" #1 sponsor was "Arrowhead Pharmaceuticals" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Emergent BioSolutions" with 1 trials sponsored and "Radius Health, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "BFHC Research" are "COVID-19" (3 trials), "Chikungunya Virus" (1 trials), "Diabetic Kidney Disease" (1 trials), "Dyslipidemias" (1 trials) and "Mixed Dyslipidemia" (1 trials). Many other conditions were trialed in "BFHC Research" in a lesser frequency.

Most popular intervention types in "BFHC Research" are "Drug" (9 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ARO-APOC3" (3 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "CHIKV VLP/adjuvant" (1 trials). Other intervention names were less common.

The vast majority of trials in "BFHC Research" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "BFHC Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in BFHC Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BFHC Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".